COYA THERAPEUTICS INC (COYA) Forecast, Price Target & Analyst Ratings

NASDAQ:COYAUS22407B1089

Current stock price

4.21 USD
-0.01 (-0.24%)
Last:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for COYA THERAPEUTICS INC (COYA).

Forecast Snapshot

Consensus Price Target

Price Target
$16.39
+ 289.38% Upside

Next Earnings Forecast

Earnings Estimate
Release Date
Mar 24, 2026
Period
Q4 / 2025
EPS Estimate
-$0.28
Revenue Estimate
1.967M

ChartMill Buy Consensus

Rating
83.08%
Weighted Analyst Rating Score

Price Target Details & History

Consensus Price Target and Range

Mean target
$16.39
Upside
+ 289.38%
From current price of $4.21 to mean target of $16.39, Based on 13 analyst forecasts
Low
$14.14
Median
$16.32
High
$18.90

Price Target Revisions

1 Month
0.00%
3 Months
0.00%

Price Target Summary

13 Wall Street analysts provided a forecast for the next 12 months for COYA. The average price target is 16.39 USD. This implies a price increase of 289.38% is expected in the next year compared to the current price of 4.21.

Analyst Ratings & History

Current Analyst Ratings

COYA Current Analyst RatingCOYA Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6 8

Analyst Ratings History

COYA Historical Analyst RatingsCOYA Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8 10

Analyst Ratings Consensus

ChartMill Buy Consensus
83.08%
COYA was analyzed by 13 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about COYA.
In the previous month the buy percentage consensus was at a similar level.
COYA was analyzed by 13 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-03-23HC Wainwright & Co.Reiterate Buy -> Buy
2026-03-19D. Boral CapitalMaintains Buy -> Buy
2026-03-16D. Boral CapitalMaintains Buy -> Buy
2026-03-16Chardan CapitalMaintains Buy -> Buy
2026-02-18D. Boral CapitalMaintains Buy -> Buy
2026-02-02HC Wainwright & Co.Reiterate Buy -> Buy
2026-01-21D. Boral CapitalMaintains Buy -> Buy
2026-01-08D. Boral CapitalMaintains Buy -> Buy
2026-01-08Chardan CapitalMaintains Buy -> Buy
2026-01-05D. Boral CapitalMaintains Buy -> Buy
2025-12-23D. Boral CapitalMaintains Buy -> Buy
2025-12-09D. Boral CapitalMaintains Buy -> Buy
2025-11-14Chardan CapitalMaintains Buy -> Buy
2025-11-13BTIGMaintains Buy -> Buy
2025-11-12D. Boral CapitalMaintains Buy -> Buy
2025-09-30BTIGReiterate Buy -> Buy
2025-09-29D. Boral CapitalMaintains Buy -> Buy
2025-09-22D. Boral CapitalMaintains Buy -> Buy
2025-09-17D. Boral CapitalMaintains Buy -> Buy
2025-09-17Chardan CapitalMaintains Buy -> Buy
2025-09-04D. Boral CapitalMaintains Buy -> Buy
2025-08-27HC Wainwright & Co.Reiterate Buy -> Buy
2025-08-25D. Boral CapitalMaintains Buy -> Buy
2025-08-25HC Wainwright & Co.Reiterate Buy -> Buy
2025-08-13D. Boral CapitalMaintains Buy -> Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
Mar 24, 2026
Period
Q4 / 2025
EPS Estimate
-$0.28
Revenue Estimate
1.967M
Revenue Q2Q
100,771.79%
EPS Q2Q
-63.72%
Number of Analysts
9

Next Earnings Revisions

Revenue (1 Month)
0.00%
Revenue (3 Months)
0.00%
EPS (1 Month)
0.00%
EPS (3 Months)
2.05%

Next Earnings Summary

COYA is expected to report earnings on 3/24/2026. The consensus EPS estimate for the next earnings is -0.28 USD and the consensus revenue estimate is 1.97M USD.
The next earnings revenue estimate has been revised downward by 0% in the past 3 months.

Full Analyst Estimates 2025 - 2033

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
COYA revenue by date.COYA revenue by date.
6.002M3.554M
-40.79%
6.04M
69.94%
1.071M
-82.27%
9.86M
820.63%
21.794M
121.03%
13.26M
-39.16%
18.856M
42.20%
118.64M
529.19%
232.72M
96.16%
351.1M
50.87%
EBITDA
YoY % growth
COYA ebitda by date.COYA ebitda by date.
-9.78M
-101.65%
-7.333M
25.02%
-17.197M
-134.53%
N/AN/AN/AN/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
COYA ebit by date.COYA ebit by date.
-9.81M
-101.44%
-7.36M
24.97%
-17.225M
-134.02%
-21.918M
-27.25%
-33.727M
-53.88%
-21.633M
35.86%
-15.846M
26.75%
-25.029M
-57.95%
-21.51M
14.06%
79.783M
470.91%
188.82M
136.67%
302.17M
60.03%
Operating Margin
COYA operating margin by date.COYA operating margin by date.
N/A-122.63%-484.64%-362.87%-3,149.13%-219.40%-72.71%-188.76%-114.07%67.25%81.14%86.06%
EPS
YoY % growth
COYA eps by date.COYA eps by date.
N/A-0.79
57.44%
-0.97
-22.78%
-1.22
-25.59%
-1.52
-24.52%
-1.19
21.55%
-0.21
82.00%
-0.34
-57.14%
0.10
130.30%
2.99
2,830.00%
6.67
123.21%
9.52
42.66%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth
-0.28
-63.72%
-0.36
18.09%
-0.42
-15.69%
-0.44
-237.38%
-0.38
-34.87%
Revenue
Q2Q % growth
1.967M
100,771.79%
214.2K
-16.98%
163.2K
-0.49%
122.4K
-96.57%
102K
-94.81%
EBITDA
Q2Q % growth
N/AN/AN/AN/AN/A
EBIT
Q2Q % growth
-5.064M
-24.10%
-7.111M
7.37%
-7.934M
-23.68%
-8.215M
-328.58%
-8.243M
-62.79%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

COYA Yearly Revenue VS EstimatesCOYA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 100M 200M 300M
COYA Yearly EPS VS EstimatesCOYA Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 2 4 6 8

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
-7.05%
EPS Next 5 Year
10.57%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
38.98%
Revenue Next 5 Year
29.27%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A

COYA THERAPEUTICS INC / COYA Forecast FAQ

Can you provide the average price target for COYA THERAPEUTICS INC stock?

13 analysts have analysed COYA and the average price target is 16.39 USD. This implies a price increase of 289.38% is expected in the next year compared to the current price of 4.21.

Can you provide the upcoming earnings date for COYA THERAPEUTICS INC?

COYA THERAPEUTICS INC (COYA) will report earnings on 2026-03-24, before the market open.

What are the consensus estimates for COYA stock next earnings?

The consensus EPS estimate for the next earnings of COYA THERAPEUTICS INC (COYA) is -0.28 USD and the consensus revenue estimate is 1.97M USD.

How do analysts rate COYA THERAPEUTICS INC (COYA)?

The consensus rating for COYA THERAPEUTICS INC (COYA) is 83.0769 / 100 . This indicates that analysts generally have a positive outlook on the stock.